Market Research Life Sciences Market Research Diagnostics Market Research In Vitro Diagnostics Market Research Molecular Diagnostics Market Research

Middle East Molecular Diagnostics Market - By Product (Systems, Kits & Consumables, Software & Other Products); By Testing Location (Laboratory Testing, Point-of-Care Testing); By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Is

Best Price Guarantee Length Publisher Published Date SKU
from $3,599 240 Pages BlueWeave Consulting March, 2023 BLWC18215617
Best Price Guarantee
Price from $3,599
Length 240 Pages
Publisher BlueWeave Consulting
Published Date March, 2023
SKU BLWC18215617

Middle East Molecular Diagnostics Market - By Product (Systems, Kits & Consumables, Software & Other Products); By Testing Location (Laboratory Testing, Point-of-Care Testing); By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Isothermal Nucleic Acid Amplification Technology (INAAT), Microarray, In-Situ Hybridization (ISH), Immunohistochemistry (IHC), Other Technologies); By Application (Core Molecular Diagnostics, Reproductive Genetics, Companion Diagnostics (CDx), Liquid Biopsy, Other Applications); By End User (Hospitals, Diagnostic Centers, Out-Patient Clinics/General Practitioners, Research Laboratories, Other End Users); By Country (Saudi Arabia, UAE, Lebanon, Bahrain, Oman, Qatar, Rest of Middle East), Trend Analysis, Competitive Landscape & Forecast, 2019–2029

Middle East Molecular Diagnostics Market Size Booming to Reach USD 919 Million by 2029

Middle East molecular diagnostics market is gaining traction because of the increasing awareness and acceptance of personalized medicines in the and significant external funding for executing R&D activities in the region.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Middle East molecular diagnostics market size at USD 527.82 million in 2022. During the forecast period between 2023 and 2029, the Middle East molecular diagnostics market size is projected to grow at an impressive CAGR of 8.3% reaching a value of USD 919.34 million by 2029. The main factors influencing the growth of this market are the increasing focus on diagnosing and treating growing cancer patient population, rapid adoption of technology advancements, and growing acceptance of customized therapy and companion diagnostic tests. Also, the market is expanding due to the increased demand for self-testing diagnostics, such as monthly diabetes testing and government-funded assistance like free COVID-19 vaccinations. In addition, the development and study of novel molecules, such as RT-PCR (Reverse Transcription Polymerase Chain Reaction) for COVID-19 testing, is boosting the demand for molecular diagnostics.

Middle East Molecular Diagnostics Market – Overview

The growing healthcare industry makes use of technology to diagnose and monitor complex conditions, detect risk, and, most importantly, select the most tailored treatments and therapies for individual patients. Molecular diagnostics is the study of how individuals express their genes as proteins and the application of medical and microbiological technology in medical imaging science to examine biological markers residing in the proteome and genome. For decades, molecular diagnostics has been regarded as a superior tool for reaching the goal of faster disease diagnosis with fewer complications. The demand for these procedures is growing, especially for diagnosing infectious diseases.

Middle East Molecular Diagnostics Market – By Application

Based on application, the Middle East molecular diagnostics market is segmented into core molecular diagnostics, reproductive genetics, companion diagnostics (CDX), liquid biopsy, and other applications. The core molecular diagnostics segment holds the highest share in the Middle East molecular diagnostics market. The increasing use of molecular testing in laboratories to treat illnesses is primarily responsible for this market segment's expansion. The majority of the Middle East's molecular diagnostics market is serviced by a wide number of inclusive core molecular diagnostics applications.

Impact of COVID-19 on the Middle East Molecular Diagnostics Market

The development of the molecular diagnostics market was aided by the improved usage of molecular diagnostic technologies for COVID-19 testing. In the Middle East, treating infectious illnesses has risen to the top of the medical priority list as a result of the COVID-19 pandemic. The demand for RT-PCR registered a sharp spike post the pandemic outbreak. According to a report published by the National Institutes of Health, “molecular diagnostic assays are a major group of tests used to diagnose COVID-19.” Reverse transcription polymerase chain reaction (RT-PCR) is now the most used technique for detecting SARS-CoV-2 RNA.

Competitive Landscape

Major players operating in the Middle East molecular diagnostics market include Abbott, Agilent Technologies, Inc., bioMerieux SA, Babirus Medical Equipment LLC, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd., Guardant Health, Illumina, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Middle East Molecular Diagnostics market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Middle East Molecular Diagnostics market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.


1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Middle East Molecular Diagnostics Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Increasing Prevalence of Infectious Diseases and Various Types of Cancer in the Middle East
3.2.1.2. Increase in Awareness and Acceptance of Personalized Medicines in the Middle East
3.2.1.3. Significant External Funding for Executing Research and Development Exercises
3.2.2. Restraints
3.2.2.1. Uncertain Reimbursement Scenario
3.2.2.2. Lack of High-Complexity Testing Centres in the Middle East
3.2.3. Opportunities
3.2.3.1. Massive Scope for Adoption of Molecular Diagnostics
3.2.3.2. Rise of Next-Generation Ultrasensitive Molecular Diagnostics
3.2.3.3. Novel Revenue Streams
3.2.4. Challenges
3.2.4.1. COVID-19 Impact on Middle East Molecular Diagnostics
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Middle East Molecular Diagnostics Market Overview
4.1. Market Size & Forecast by Value, 2019–2029
4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
4.2.1. By Product
4.2.1.1. Systems
4.2.1.2. Kits & Consumables
4.2.1.3. Software
4.2.1.4. Other Product
4.2.2. By Testing Location
4.2.2.1. Laboratory Testing
4.2.2.2. Point-of-Care Testing
4.2.3. By Technology
4.2.3.1. Polymerase Chain Reaction (PCR)
4.2.3.2. Next-Generation Sequencing
4.2.3.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
4.2.3.4. Microarray
4.2.3.5. In-Situ Hybridization (ISH)
4.2.3.6. Immunohistochemistry (IHC)
4.2.3.7. Other Technologies
4.2.4. By Application
4.2.4.1. Core Molecular Diagnostics
4.2.4.2. Reproductive Genetics
4.2.4.3. Companion Diagnostics (CDx)
4.2.4.4. Liquid Biopsy
4.2.4.5. Other Applications
4.2.5. By End User
4.2.5.1. Hospitals
4.2.5.2. Diagnostic Centres
4.2.5.3. Out-Patient Clinics/General Practitioners
4.2.5.4. Research Laboratories
4.2.5.5. Other End Users
4.2.6. By Country
4.2.6.1. Saudi Arabia
4.2.6.2. UAE
4.2.6.3. Lebanon
4.2.6.4. Bahrain
4.2.6.5. Oman
4.2.6.6. Qatar
4.2.6.7. Rest of Middle East
5. Saudi Arabia Molecular Diagnostics Market
5.1.1. Market Size & Forecast by Value, 2019–2 029
5.1.2. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product
5.2.2. By Testing Location
5.2.3. By Technology
5.2.4. By Application
5.2.5. By End Users
6. UAE Molecular Diagnostics Market
6.1.1. Market Size & Forecast by Value, 2019–2 029
6.1.2. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Testing Location
6.2.3. By Technology
6.2.4. By Application
6.2.5. By End Users
7. Lebanon Molecular Diagnostics Market
7.1. Market Size & Forecast by Value, 2019–2 029
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Testing Location
7.2.3. By Technology
7.2.4. By Application
7.2.5. By End Users
8. Bahrain Molecular Diagnostics Market
8.1. Market Size & Forecast by Value, 2019–2 029
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Testing Location
8.2.3. By Technology
8.2.4. By Application
8.2.5. By End Users
9. Oman Molecular Diagnostics Market
9.1. Market Size & Forecast by Value, 2019–2 029
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Testing Location
9.2.3. By Technology
9.2.4. By Application
9.2.5. By End Users
10. Qatar Molecular Diagnostics Market
10.1. Market Size & Forecast by Value, 2019–2 029
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Testing Location
10.2.3. By Technology
10.2.4. By Application
10.2.5. By End Users
11. Rest of Middle East Molecular Diagnostics Market
11.1. Market Size & Forecast by Value, 2019–2 029
11.1.1. By Value (USD Million)
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Testing Location
11.2.3. By Technology
11.2.4. By Application
11.2.5. By End Users
12. Competitive Landscape
12.1. List of Key Players and Their Offerings
12.2. Middle East Molecular Diagnostics Company Market Share Analysis, 2022
12.3. Competitive Benchmarking, By Operating Parameters
12.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, and others)
13. Impact of Covid-19 on Middle East Molecular Diagnostics Market
14. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
14.1. Abbott
14.2. Agilent Technologies, Inc.
14.3. bioMerieux SA
14.4. Babirus Medical Equipment LLC
14.5. Bio-Rad Laboratories, Inc.
14.6. Danaher
14.7. F. Hoffmann-La Roche Ltd.
14.8. Guardant Health
14.9. Illumina, Inc.
14.10. QIAGEN N.V.
14.11. Thermo Fisher Scientific Inc
14.12. Other prominent players.
15. Key Strategic Recommendations
16. Research Methodology
16.1. Qualitative Research
16.1.1. Primary & Secondary Research
16.2. Quantitative Research
16.3. Market Breakdown & Data Triangulation
16.3.1. Secondary Research
16.3.2. Primary Research
16.4. Breakdown of Primary Research Respondents, By Region
16.5. Assumption & Limitation
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Figures
Figure 1 Middle East Molecular Diagnostics Market Segmentation
Figure 2 Middle East Molecular Diagnostics Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2022
Figure 4 Middle East Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029
Figure 5 Middle East Molecular Diagnostics Market Share, By Product, By Value, 2019–2029
Figure 6 Middle East Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029
Figure 7 Middle East Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029
Figure 8 Middle East Molecular Diagnostics Market Share, By Application, By Value, 2019–2029
Figure 9 Middle East Molecular Diagnostics Market Share, By End User, By Value, 2019–2029
Figure 10 Middle East Molecular Diagnostics Market Share, By Country, By Value, 2019–2029
Figure 11 Saudi Arabia Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029
Figure 12 Saudi Arabia Molecular Diagnostics Market Share, By Product, By Value, 2019–2029
Figure 13 Saudi Arabia Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029
Figure 14 Saudi Arabia Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029
Figure 15 Saudi Arabia Molecular Diagnostics Market Share, By Application, By Value, 2019–2029
Figure 16 Saudi Arabia Molecular Diagnostics Market Share, By End User, By Value, 2019–2029
Figure 17 UAE Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029
Figure 18 UAE Molecular Diagnostics Market Share, By Product, By Value, 2019–2029
Figure 19 UAE Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029
Figure 20 UAE Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029
Figure 21 UAE Molecular Diagnostics Market Share, By Application, By Value, 2019–2029
Figure 22 UAE Molecular Diagnostics Market Share, By End User, By Value, 2019–2029
Figure 23 Lebanon Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029
Figure 24 Lebanon Molecular Diagnostics Market Share, By Product, By Value, 2019–2029
Figure 25 Lebanon Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029
Figure 26 Lebanon Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029
Figure 27 Lebanon Molecular Diagnostics Market Share, By Application, By Value, 2019–2029
Figure 28 Lebanon Molecular Diagnostics Market Share, By End User, By Value, 2019–2029
Figure 29 Bahrain Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029
Figure 30 Bahrain Molecular Diagnostics Market Share, By Product, By Value, 2019–2029
Figure 31 Bahrain Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029
Figure 32 Bahrain Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029
Figure 33 Bahrain Molecular Diagnostics Market Share, By Application, By Value, 2019–2029
Figure 34 Bahrain Molecular Diagnostics Market Share, By End User, By Value, 2019–2029
Figure 35 Oman Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029
Figure 36 Oman Molecular Diagnostics Market Share, By Product, By Value, 2019–2029
Figure 37 Oman Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029
Figure 38 Oman Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029
Figure 39 Oman Molecular Diagnostics Market Share, By Application, By Value, 2019–2029
Figure 40 Oman Molecular Diagnostics Market Share, By End User, By Value, 2019–2029
Figure 41 Qatar Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029
Figure 42 Qatar Molecular Diagnostics Market Share, By Product, By Value, 2019–2029
Figure 43 Qatar Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029
Figure 44 Qatar Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029
Figure 45 Qatar Molecular Diagnostics Market Share, By Application, By Value, 2019–2029
Figure 46 Qatar Molecular Diagnostics Market Share, By End User, By Value, 2019–2029
Figure 47 Rest of Middle East Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029
Figure 48 Rest of Middle East Molecular Diagnostics Market Share, By Product, By Value, 2019–2029
Figure 49 Rest of Middle East Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029
Figure 50 Rest of Middle East Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029
Figure 51 Rest of Middle East Molecular Diagnostics Market Share, By Application, By Value, 2019–2029
Figure 52 Rest of Middle East Molecular Diagnostics Market Share, By End User, By Value, 2019–2029
List of Tables
Table 1 Middle East Molecular Diagnostics Market Size, By Product, By Value, 2019–2029
Table 2 Middle East Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029
Table 3 Middle East Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029
Table 4 Middle East Molecular Diagnostics Market Size, By Application, By Value, 2019–2029
Table 5 Middle East Molecular Diagnostics Market Size, By End User, By Value, 2019–2029
Table 6 Middle East Molecular Diagnostics Market Size, By Country, By Value, 2019–2029
Table 7 Saudi Arabia Molecular Diagnostics Market Size, By Product, By Value, 2019–2029
Table 8 Saudi Arabia Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029
Table 9 Saudi Arabia Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029
Table 10 Saudi Arabia Molecular Diagnostics Market Size, By Application, By Value, 2019–2029
Table 11 Saudi Arabia Molecular Diagnostics Market Size, By End User, By Value, 2019–2029
Table 12 UAE Molecular Diagnostics Market Size, By Product, By Value, 2019–2029
Table 13 UAE Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029
Table 14 UAE Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029
Table 15 UAE Molecular Diagnostics Market Size, By Application, By Value, 2019–2029
Table 16 UAE Molecular Diagnostics Market Size, By End User, By Value, 2019–2029
Table 17 Lebanon Molecular Diagnostics Market Size, By Product, By Value, 2019–2029
Table 18 Lebanon Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029
Table 19 Lebanon Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029
Table 20 Lebanon Molecular Diagnostics Market Size, By Application, By Value, 2019–2029
Table 21 Lebanon Molecular Diagnostics Market Size, By End User, By Value, 2019–2029
Table 22 Bahrain Molecular Diagnostics Market Size, By Product, By Value, 2019–2029
Table 23 Bahrain Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029
Table 24 Bahrain Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029
Table 25 Bahrain Molecular Diagnostics Market Size, By Application, By Value, 2019–2029
Table 26 Bahrain Molecular Diagnostics Market Size, By End User, By Value, 2019–2029
Table 27 Oman Molecular Diagnostics Market Size, By Product, By Value, 2019–2029
Table 28 Oman Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029
Table 29 Oman Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029
Table 30 Oman Molecular Diagnostics Market Size, By Application, By Value, 2019–2029
Table 31 Oman Molecular Diagnostics Market Size, By End User, By Value, 2019–2029
Table 32 Qatar Molecular Diagnostics Market Size, By Product, By Value, 2019–2029
Table 33 Qatar Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029
Table 34 Qatar Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029
Table 35 Qatar Molecular Diagnostics Market Size, By Application, By Value, 2019–2029
Table 36 Qatar Molecular Diagnostics Market Size, By End User, By Value, 2019–2029
Table 37 Rest of Middle East Molecular Diagnostics Market Size, By Product, By Value, 2019–2029
Table 38 Rest of Middle East Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029
Table 39 Rest of Middle East Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029
Table 40 Rest of Middle East Molecular Diagnostics Market Size, By Application, By Value, 2019–2029
Table 41 Rest of Middle East Molecular Diagnostics Market Size, By End User, By Value, 2019–2029
Table 42 Abbott Company Overview
Table 43 Abbott Financial Overview
Table 44 Agilent Technologies, Inc. Company Overview
Table 45 Agilent Technologies, Inc. Financial Overview
Table 46 bioMerieux SA Company Overview
Table 47 bioMerieux SA Financial Overview
Table 48 Babirus Medical Equipment LLC Company Overview
Table 49 Babirus Medical Equipment LLC Financial Overview
Table 50 Bio-Rad Laboratories, Inc. Company Overview
Table 51 Bio-Rad Laboratories, Inc. Financial Overview
Table 52 Danaher Company Overview
Table 53 Danaher Financial Overview
Table 54 F. Hoffmann-La Roche Ltd. Company Overview
Table 55 F. Hoffmann-La Roche Ltd. Financial Overview
Table 56 Guardant Health Company Overview
Table 57 Guardant Health Financial Overview
Table 58 Illumina, Inc. Company Overview
Table 59 Illumina, Inc. Financial Overview
Table 60 QIAGEN N.V. Company Overview
Table 61 QIAGEN N.V. Financial Overview
Table 62 Thermo Fisher Scientific Inc Company Overview
Table 63 Thermo Fisher Scientific Inc Financial Overview

$3,599
$4,000
$4,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings